Astec Lifesciences Ltd

Astec Lifescienc Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Astec Lifesciences Ltd

₹ 1,296 18.64%
29 Mar 4:01 p.m.
astecls.com BSE: 533138 NSE : ASTEC
About

The Company is into manufacturing of agrochemical active ingredients (technical), bulk and formulations, intermediate products and it sells its products in India as well as exports them to approximately 24 countries.
Astec also has undertaken a number of custom synthesis projects, for its clients in Europe, Japan and the US. It is present only in business to business sale (B2B).[1] [2] [3]

Key Points

Acquisition of Stake by Godrej Agrovet
In 2015, Godrej Agrovet purchased 45.29% at Rs 190 in October, 2015 and further acquired 6.99% at a price of Rs 240 in December, 2015 (Currently holding 62.33%).[1] [2]

Website BSE NSE
  • Market Cap ₹ 2,569 Cr.
  • Current Price ₹ 1,296
  • High / Low ₹ 2,289 / 1,045
  • Stock P/E 34.9
  • Book Value ₹ 216
  • Dividend Yield 0.11 %
  • ROCE 22.2 %
  • ROE 25.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter
  • Company has delivered good profit growth of 27.8% CAGR over last 5 years
  • Company's median sales growth is 21.3% of last 10 years

Cons

  • Company might be capitalizing the interest cost
  • Working capital days have increased from 114 days to 163 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
124.83 180.57 111.94 155.00 116.01 171.92 128.66 102.57 173.35 271.98 184.27 199.75 117.18
103.99 137.88 83.66 125.50 100.42 133.73 103.99 81.49 130.49 206.52 158.82 166.48 105.05
Operating Profit 20.84 42.69 28.28 29.50 15.59 38.19 24.67 21.08 42.86 65.46 25.45 33.27 12.13
OPM % 16.69% 23.64% 25.26% 19.03% 13.44% 22.21% 19.17% 20.55% 24.72% 24.07% 13.81% 16.66% 10.35%
3.93 5.24 1.25 1.85 3.27 1.55 0.80 0.90 1.96 6.80 2.71 3.99 3.79
Interest 3.38 2.15 1.53 1.13 1.06 1.04 1.53 1.65 2.56 3.32 3.92 4.51 5.88
Depreciation 5.78 6.15 6.26 6.34 6.52 6.53 6.51 8.15 9.06 10.64 8.93 8.17 8.80
Profit before tax 15.61 39.63 21.74 23.88 11.28 32.17 17.43 12.18 33.20 58.30 15.31 24.58 1.24
Tax % 22.10% 21.32% 25.53% 25.25% 37.32% 25.52% 25.53% 25.53% 25.48% 26.14% 25.47% 25.47% 31.45%
Net Profit 12.16 31.19 16.18 17.85 7.07 23.97 12.99 9.08 24.76 43.06 11.41 18.32 0.85
EPS in Rs 6.21 15.93 8.27 9.12 3.61 12.23 6.63 4.63 12.63 21.97 5.82 9.34 0.43
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
109 112 174 207 267 233 299 368 431 523 555 677 773
94 97 146 171 213 201 236 299 354 437 443 522 637
Operating Profit 16 16 28 35 54 32 63 69 76 85 112 154 136
OPM % 15% 14% 16% 17% 20% 14% 21% 19% 18% 16% 20% 23% 18%
1 1 0 -0 -16 4 -8 12 11 12 8 10 17
Interest 4 6 7 9 13 13 12 11 12 13 5 9 18
Depreciation 6 9 12 15 13 10 14 15 19 23 26 34 37
Profit before tax 7 2 9 11 13 12 29 56 56 61 89 121 99
Tax % 30% 29% 32% 22% -17% 59% 33% 37% 36% 23% 27% 26%
Net Profit 5 1 6 9 15 5 19 35 36 48 65 90 74
EPS in Rs 2.89 0.81 3.30 4.68 7.60 2.55 9.80 17.87 18.28 24.28 33.21 45.85 37.56
Dividend Payout % 17% 62% 23% 21% 16% -0% 15% 8% 8% 6% 5% 3%
Compounded Sales Growth
10 Years: 20%
5 Years: 18%
3 Years: 16%
TTM: 34%
Compounded Profit Growth
10 Years: 53%
5 Years: 28%
3 Years: 36%
TTM: 4%
Stock Price CAGR
10 Years: 55%
5 Years: 18%
3 Years: 52%
1 Year: -25%
Return on Equity
10 Years: 19%
5 Years: 23%
3 Years: 24%
Last Year: 25%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
17 17 18 19 19 19 20 20 20 20 20 20 20
Reserves 80 80 87 95 116 99 119 150 183 227 290 377 404
41 74 73 83 93 127 127 125 176 99 187 279 321
36 60 83 88 133 85 69 119 83 226 181 221 210
Total Liabilities 174 231 261 284 362 330 334 413 461 572 678 897 954
73 76 121 132 133 95 103 115 167 194 213 340 342
CWIP 9 44 13 6 12 20 8 42 19 24 116 23 27
Investments 8 12 0 0 0 0 0 0 0 0 0 0 0
84 100 127 146 216 215 223 256 275 354 349 534 586
Total Assets 174 231 261 284 362 330 334 413 461 572 678 897 954

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
16 -0 16 15 7 -13 19 65 15 168 -8 24
-17 -0 -13 -19 -19 -17 -18 -49 -52 -74 -73 -104
2 -0 -2 3 12 31 -1 -18 37 -95 81 80
Net Cash Flow 1 -0 1 -1 -0 2 1 -3 -0 0 0 0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 114 103 131 91 142 126 135 122 103 112 123 148
Inventory Days 165 237 145 192 147 177 133 122 121 131 113 176
Days Payable 102 146 132 114 179 169 116 155 83 218 137 179
Cash Conversion Cycle 177 195 145 168 109 134 152 89 142 25 100 145
Working Capital Days 170 179 122 125 125 142 154 115 147 77 101 163
ROCE % 8% 5% 9% 11% 20% 12% 20% 22% 20% 20% 22% 22%

Shareholding Pattern

Numbers in percentages

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
71.33 72.30 69.96 65.23 65.23 65.20 65.20 65.19 65.29 65.29 66.77 66.76
0.84 0.55 0.56 0.66 0.25 0.19 0.22 0.29 0.32 0.48 1.53 2.19
0.51 0.29 0.89 6.53 10.67 10.93 12.21 12.74 12.56 11.79 9.82 9.57
27.32 26.85 28.59 27.57 23.85 23.68 22.37 21.78 21.83 22.45 21.87 21.49

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls